Health Checkup, Medical Treatment & Elective Surgeries
MedEx connects you to JCI accredited world-class hospitals with outstanding certifications
Click here to login
Please select date*
Name*
Email*
Contact Number
No. of Attendee(s)*
1
Pay with Stripe if you are paying with a local or international card, or Select alternative payment methods
Top Searches :
Click here to login
Please select date and time*
Name*
Email*
Contact Number
No. of Attendee(s)*
1
Pay with Stripe if you are paying with a local or international card, or Select alternative payment methods
<p>Quantitatively measures BCR-ABL gene transcripts to monitor CML treatment at MedEx Neo Clinic, Kathmandu.</p>
BCR-ABL Quantitative, MRD Monitor Test at MedEx Neo Clinic, Kathmandu
This molecular test quantitatively measures BCR-ABL fusion gene transcripts for monitoring minimal residual disease (MRD) in chronic myeloid leukemia (CML). Available at MedEx Neo Clinic, Kathmandu, it guides treatment response evaluation.
Why is it important? Assesses effectiveness of therapy and detects relapse early.
Who should take this test? CML patients undergoing treatment.
Test method: Quantitative PCR analysis of blood samples.